0910-AD66 0910-AA02 199910 The Regulatory Plan and the Unified Agenda of Federal Regulatory and Deregulatory Actions 0910 Food and Drug Administration FDA 0900 Department of Health and Human Services HHS New Animal Drug Approval Process Substantive, Nonsignificant Previously Published in The Unified Agenda Final Rule Stage Undetermined No 21 CFR 514 21 USC 321 21 USC 351 21 USC 352 21 USC 360b 21 USC 371 21 USC 379e 21 USC 381 Statutory Final 11/16/1989 The deadline applies to the GADPTRA sections. There is no deadline relating to the other sections. No NPRM 12/17/1991 56 FR 65544 NPRM To Be Determined Previously reported under RIN 0905-AA96. For information concerning reporting requirements for marketed animal drugs, contact William C. Keller, Director, Division of Epidemiology and Surveillance, Center for Veterinary Medicine, Food and Drug Administration, 7500 Standish Place, Rockville, MD 20855, 301 827-6642. For further information concerning generic animal drugs, contact Lonnie W. Luther, Chief, Quality Assurance Support Team, Center for Veterinary Medicine, Food and Drug Administration, 7500 Standish Place, Rockville, MD 20855, 301 827-0209. Yes Businesses None NA Not Collected Not Procurement Related Revising Text to Reduce Burden or Duplication, or Streamline Requirements